Evidence map›Paper›PMID 37124372›Full record

ReviewTherapeutic advances in gastroenterology2023

Therapeutic eradication choices in

Marco Manfredi, Giancarlo Gargano, Pierpacifico Gismondi, Bernardino Ferrari, Silvia Iuliano

Open access · goldAbstract readReview
In one paragraph

Review in Therapeutic advances in gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Frontiers in pediatrics · 2026
    Article
  5. Review
  6. JPGN reports · 2025
    Article
  7. Review
  8. Frontiers in immunology · 2024
    Review
  9. Frontiers in pharmacology · 2024
    Article
  10. Adequate amounts of probiotics increase the success rate ofTherapeutic advances in gastroenterology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Marco ManfrediChief of Pediatric Unit, Maternal and Child Department, Azienda USL-IRCCS di Reggio Emilia, Sant'Anna Hospital, Castelnovo ne' Monti, Via Roma, 2, Reggio Emilia 42035, Italy.ORCID https://orcid.org/0000-0003-4473-1123
Giancarlo GarganoMaternal and Child Department, Azienda USL-IRCCS di Reggio Emilia, ASMN Hospital, Reggio Emilia, Italy.
Pierpacifico GismondiWeek Hospital Unit, Department of Pediatrics, "Pietro Barilla" Children's Hospital, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Bernardino FerrariPediatric Unit, ASST Franciacorta, Public Hospital, Iseo, Brescia, Italy.
Silvia IulianoPediatric Gastroenterology, Department of Pediatrics, "Pietro Barilla" Children's Hospital, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Ospedale di Parma · ITAzienda Sanitaria Unità Locale di Reggio Emilia · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current recommendations on

Indexed as

adjuvantschildrencombination therapyeradication treatmentHelicobacter pylorisusceptibility testing

Identifiers

PMID37124372
PMCPMC10141265
OpenAlexW4367278823

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.